1. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the advisory committee on immunization practices (ACIP);Liang;MMWR Recommend Rep/Centers Dis Control,2018
2. Pertussis/Whooping Cough (Bordetella pertussis). Centers for Disease Control and Prevention National Notifiable Disease Surveillance System (NNDSS). Atlanta, GA. https://wwwn.cdc.gov/nndss/conditions/pertussis/. Accessed September 6, 2019.
3. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morbidity and mortality weekly report 2012. p. 468–70.
4. Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4–5 years after a previous dose;Halperin;Vaccine,2011
5. Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: an open, phase III, non-randomized, multi-center study;Kovac;Hum Vacc Immunotherap,2018